FC2Video

Genomma Lab Internacional, S.A.B. de C.V. reported that it has submitted a non-binding proposal to acquire all of the outstanding shares of Prestige Brands Holdings Inc - PBH - common stock for $16.60 dollars per share in cash.

CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012.